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The characterization of 255 Bacillus thuringiensis isolates of Coorg, Sharavatti and BR hills, containing 
genes known to be active against coleopteran and lepidopteran insect species was done through PCR 
amplification using the specific and degenerate primers. The isolates were also tested for their 
insecticidal activity against Plutella xylostella. Among the coleopteran specific genes screened, the 
most predominant was cry1I gene which was present in 18 isolates at a frequency of 7.05%. cry1 gene 
was found to be most abundant (35.39%) among the lepidopteran specific genes. A variant of cry1I gene 
based on amplicon restriction fragment length polymorphism (ARFLP) was cloned into pTZ57R/T and 
subcloned in an expression vector pQE-30 after amplification of a 2169 bp DNA fragment of cry1I gene 
from B. thuringiensis DBT189, the sequence which showed 99% homology with known cry1Ia gene from 
B. thuringiensis subsp. kurstaki. There were six mismatches between the two amino acid sequences. 
The cry1I- type gene consisted of an open reading frame of 2124 bp that would encode for 720 amino 
acids. An expected band size of 81 kDa was observed after sodium dodecyl sulphate- polyacrylamide 
gel electrophoresis (SDS-PAGE) analysis indicating the expression of cry1I gene. 
 





Chemical insecticides have caused an immense emer-
gence of resistant biotypes no longer controlled by major 
groups of chemical insecticides. This has led to an 
increased emphasis in environment friendly insect control 
strategies to ensure sustainability of the environment 
(Ozturk et al., 2009). One alternative approach that has 
received attention is the development of Bacillus 
thuringiensis (Bt) toxins as insecticides. B. thuringiensis 
is a Gram positive, facultative anaerobic, motile bacte-
rium which is entamopathogenic (Schnepf et al., 1998). 
The Cry protein synthesized during sporulation enables it 
to be pesticidal to a range of insect species.  
The genes encoding for the crystal proteins are named 
as cry genes, and their common characteristic is the ex-
pression of the genes during the stationary phase. To 
date, genes encoding the Cry toxins have been classified 
into 72 groups divided into class and subclasses accor-
ding to their amino acid similarity 
(http://www.lifesci.sussex.ac.uk/home/neil_crickmore/Btto
xin.html). Different Cry proteins have various insecticidal 
spectra. Wang et al. (2003) reported that Cry1, Cry2 and 
Cry9 groups exhibit strongest activity to lepidopteran 
insects; the Cry3, Cry7 and Cry8 groups are most toxic to 
coleopteran insects whereas Cry4 and Cry11 are most
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Table 1. Reference strains used in the study. 
 
Original code BGSC No. Genes harboured as per previous studies 
B. thuringiensis sub.sp.kurstaki HD1 
cry1I, cry18, cry23, cry26, cry28, cry1Aa1, 
cry1Ab2, cry1Ac1, cry1Ia1, cry2Aa1, cry2Ab1 
   
B. thuringiensis sub sp. sotto 4E2 cry14 
B. thuringiensis sub sp. japonensis 4AT1 cry7,8; cry9 
B. thuringiensis sub sp. tenebrionis 4AA1 cry3 
B. thuringiensis sub sp. fukukaensis 4AP1 cry20 




toxic to dipteran insects. 
The type of the toxin gene and the variety of such 
genes present in a strain of B. thuringiensis determine its 
level of toxicity and the host range (Hofte et al., 1989). 
Cloning of such toxin genes has helped in studying 
specific toxins and isolation of novel Bt strains may lead 
to the discovery of additional insecticidal proteins with 
higher toxicity and wider spectrum. Novel toxins are also 
important for providing alternatives to cope with the emer-
gence of resistant insect populations. This study was 
focused on characterization of Bt strains which would 
help in understanding the role of Bt in native environment 
and the diversity of cry genes. An attempt was made to 
clone a variant of cry1I based on ARFLP profile which 
would be helpful in developing new biopesticides with 
broader and higher spectrum of toxicity against insect 
pests belonging to order Coleoptera. 
 
 
MATERIALS AND METHODS 
 
B. thuringiensis strains, plasmids 
 
About 255 B. thuringiensis isolates and reference strains B. 
thuringiensis subsp. kurstaki HD1, B. thuringiensis sub sp. 
japonensis 4AT1, B. thuringiensis sub sp. tenebrionis 4AA1, B. 
thuringiensis sub sp. sotto 4E2 and B. thuringiensis sub sp. kurstaki 
4D4 (Table 1) were obtained from the culture collection maintained 
at the Department of Biotechnology, UAS, Dharwad, India. About 
113 isolates from Coorg were screened for the presence of 
lepidopteran and coleopteran specific cry genes. All 255 isolates 
inclusive of isolates from both Coorg and BR Hills were used for 
screening of coleopteran specific cry genes. The T/A cloning vector 
pTZ 57R/T was obtained from InsTAclone PCR Cloning Kit #K1213, 
Fermentas and pQE-30 from Qiagen (Cat. No. 32915). 
 
 
Preparation of B. thuringiensis culture for bioassay 
 
Individual native isolates harbouring lepidopteran specific genes 
were screened by following the leaf dip bioassay method against 
Plutella xylostella along with reference strain B. thuringiensis subsp. 
kurstaki (HD1). Individual isolates were streaked on plain Luria agar 
(Maniatis et al., 1982) plates and overnight incubated at 37°C. 
Overnight, culture was inoculated in 1 ml Luria in Eppendorf tube 
and kept for growth (sporulation) under shaking condition at 28°C 
for 24 h. The culture was re-inoculated in 100 ml modified ‘G’ 
medium (MGM) broth (Aronson et al., 1971) in a conical flask and 
kept for 72 h at 30°C on a shaker at 200 rpm. The culture was 
serially diluted at 9:1 (900 µl of sterile water and 100 µl of culture) 
and spread on plane Luria Agar plates for taking colony count 
before arriving at the concentration of B. thuringiensis (1.2 × 10
6
 
cfu/ml) to assess its toxicity against test insects. 
 
Dosage = 1.2 × 10
6 





Preliminary leaf dip bioassays for strains containing lepidopteran 
active cry genes was performed against P. xylostella as described 
by Tabashnik and Cushing (1987). 
 
 
PCR analysis for cry gene content 
 
The total DNA was isolated following the method described by 
Sambrook and Russell (2001). The cry specific primers were 
standardized for annealing temperature by gradient PCR for each 
set of specific and degenerate primers against total DNA of 
reference strains respectively. The oligonucleotide sequences of 
PCR primers and expected size of PCR products of each cry gene 
are shown in Table 2a and b. The reaction mixture varied 
depending on whether it is a gene specific primer or degenerate 
primer (10 µl for specific primer and 15 µl for degenerate primer). 
One of the gene namely, cry1I was selected for further cloning and 
analysis of expression. 
 
 
Amplification of cry1I gene 
 
Gene specific primer which was synthesized at Sigma Aldrich Pvt. 
Ltd., Bangalore, was used for amplification of cry1I gene. The 
forward and reverse primers used were 5’ 
GGATCCATGAAACTAAAGAATCAAGATAAGC 3’ and  
3’ CTGCAGCATGTTACGCTCAATATGGAGT 5’, respectively. PCR 
was performed with 3U Taq DNA polymerase, 1 mM dNTP, 5 pM 
primer each, 25 mM MgCl2 in a final volume of 100 µl. Amplification 
was done in an Eppendoff thermal cycler under the following 
conditions: 5 min of denaturation at 94°C followed by 35 cycles of 
amplification with a 1 min denaturation at 94°C, 1 min of annealing 




Amplicon restriction fragment length polymorphism (ARFLP) 
 
The novelty of the amplified cry genes was done through amplicon 
restriction fragment length polymorphism (ARFLP) as performed in 
earlier studies (Kuo et al., 1996) and the amplicon that gave a 
different ARFLP profile as compared to reference strain B. 
thuringiensis var. kurstaki was cloned in pTZ57R/T and later 
expressed in Escherichia coli M15 and E. coli SG13009. 




Table 2a. List of cry primers employed for detection of coleopteran specific cry genes in individual isolates. 
 
Gene Sequence Size (bp) Reference 
cry1I (specific) 
FP: ACAATTTACAGCTTATTAAG 
1134 This study 
RP: CTACATGTTACGCTCAATAT 
    
cry1I (full length) 
FP: GGATCCATGAAACTAAAGAATCAAGATAAGC 
2169 This study 
RP: CTGCAGCATGTTACGCTCAATATGGAGT 
    
cry3 
FP: CGTTATCGCAGAGATGACATTAAC 
589 This study 
RP: CATCTGTTGTTTCTGGAGGCAAT 
    
cry7,8 
FP: CCCTTTAGCAAACGATCAAACG 
741 This study 
RP: ATTGGGCGGTACGTGTCACCTGAC 
    
cry14 
FP: ATAATGCGCGACCTACTGTTGT 
456 This study 
RP: TGCCGTTATCGCCGTTATT 
    
cry18 
FP: CCGAGGCGATTTGGATAGAT 
419 This study 
RP: TGCCGGTGTAAACAAAGAAGG 
    
cry26 
FP: CGCGCTGTTCAATTATCAAGTGC 




    
cry28 
FP: TACAGTCGCTGTAGTAAGCGCA 
862 This study 
RP: TGACAGCCAAGTAAATAGCCCTG 
    
cry34 
FP: ATGTCAGCTCGCGAAGTACA 
313 This study 
RP: TATCTCCTGATCCGCTTTGAG 
    
cry35 
FP: AGTCTTGATGATTCAGGTGTTA 
479 This study 
RP: CAAGGTACTAATGTCCATCCCATT 
    
cry36 
FP: CTTGTGGATGTGGTTGCCAGCAA 
1399 This study 
RP: CCTCCAAATGTTTGAGCAGCTGTA 
    
cry23 
FP: CTGTATCGTTCACATGGACGGAA 
476 This study 
RP: AATGCTTCGCAAGCCTTGTGCA 
    
cry37 
FP: AAGTAGCGACACTGGTTCCCCTA 
140 This study 
RP: CAAGTCGTACTGTTACACCAGG 
    
cry55 
FP: AGCTCAAACGTTCTAGTCCCAG 





Table 2b. List of cry primers employed for detection of lepidopteran specific genes in individual isolates. 
 
 Gene Sequence Size (bp) Reference 
cry1 (degenerate) 
FP: AGGCGGTGAATGMBCTGTTTAC 
930 Johnson (2011) 
RP: CGTTTATCHGCCGCRTGAATC 
    
cry2 
FP: GTTATTCTTAATGCAGATGAATGGG 
689-701 Ben dov et al. (1997) 
RP:CGGATAAAATAATCTGGGAAATAGT 








900 Johnson (2011) 
RP:CATATCTWTRRTTCGGTTGRACTGTA 
    
cry9 (degenerate) 
FP: GGTTCTCAAAGATCCGTGTA 
1050 Juarez Perez et al. (1997) 
RP: MDATYTCTAKRTCTTGACTA 
    
cry20 
FP: CAATCCCTGGCTTCACTCGT 
490 Ejiofar and Johnson (2002) 
RP: CCGCGGGCATTAGGATT 
    
cry1Aa1 
FP: GGCAACTATACAGATTATGC 
635 Designed during the study 
RP: TCTAGTGAATCGACTGTACC 
    
cry1Ab2 
FP: AGGAAGTATTAGGAGTCCAC 
639 Designed during the study 
RP: ATATCTCCTCCTGTAAATCC 
    
cry1Ac1 
FP: TCCTTAGACATTGATGTAGG 
680 Designed during the study 
RP: TCTGTATTGTTCTCGATCTC 
    
cry1Ad1 
FP: GTCAGGACATCAAATAACAG 
546 Designed during the study 
RP: ATATCTCCTCCTGTAAATCC 
    
cry1Ae1 
FP: TAGGTGTATGGGTGATATTC 
536 Designed during the study 
RP: AACTTCTTGTGACACTTCTG 
    
cry1Ca1 
FP: CCAAACTATGACAATAGGAG 
615 Designed during the study 
RP: CCAAGAAAATACTACACCAG 
    
cry1Da1 
FP: GTAGCAGACATTTCATTAGG 
503 Designed during the study 
RP: ACATGAATAAGGCTAGTCAG 
    
cry1Ea1 
FP: ATATAGAAGTAGGGGGACAG 
694 Designed during the study 
RP: TAGCCCTAGTTGATTTGTAG 
    
cry1Fa1 
FP: GATTTGCTAATACAGACGAC 
580 Designed during the study 
RP: CGTGAACTCACTAAGTGTCC 
    
cry1Ia1 
FP: AGTACCTAGGGTTGATTTTC 
379 Designed during the study 
RP: TGTACCAGTATTCGTTCTTC 
    
cry2Aa1 
FP: ATGCGTATAATGTAGTAGCC 
466 Designed during the study 
RP: TATCCTTGTATCTGGAACTG 
    
cry2Ab1 
FP: ATGTATCTATCTGGTCGTTG 
455 Designed during the study 
RP: ACTCCTTAACCCTAAAGTTG 
    
cry2Ac1 
FP: AAAGCCTTCTAGTATCTTCC 
521 Designed during the study 
RP: TAGAGGTCTTGCTAAATCTG 
    
cry9Aa1 
FP: ATCGTAGAGAGTGACATTG 
376 Designed during the study 
RP: TGTTGTCCAGAGATTAGTTC 
    
cry9Ca1 
FP: GGATCTAAATGCAAGTGTAG 
697 Designed during the study 
RP: ACCATTTACATCGTAGTCAC 
 




Molecular cloning and nucleotide sequencing 
 
PCR  amplified  products  were  ligated  to  the  T/A  cloning vector  
pTZ57R/T (Sambrook and Russell, 2001) using the Fermentas DNA 
ligation kit. The transformed cells were spread on LB agar plates 





(IPTG) (24 mg/ml) and ampicillin (100 µg/ml). The plates were then 
incubated at 37°C for 12 to 16 h and the transformed colonies were 
further streaked on Luria agar with ampicillin (100 μg/ml). The 
confirmation for the presence of desired DNA fragment in cloning 
vector was done by PCR using gene specific primers and by restric-
tion analysis. Nucleotide sequencing was done by using M13 
forward and reverse primer at Chromous Biotech Pvt. Ltd., Bangalore. 
In order to express the cry1I gene, the construct containing cry1I 
was inserted into the multiple cloning site of an expression vector 
pQE30 to generate the recombinant expression construct 
pAPK3A01. The complete amplified gene was gel purified using the 
Mini Elute PCR purification kit (Qiagen) according to the manufac-
turer’s instructions. The insert sequence and its reading frame were 
confirmed by BamHI and PstI digestion. The ligated product was 
first transferred into E. coli JM109 cells for maintenance and then 
into E. coli M15 (pREP4) (Qiagen) and E. coli SG13009 (pREP) 
(Qiagen) for expression analysis. 
For confirmation of the clones, the plasmid was isolated by using 
alkaline lysis protocol of Birmboim and Doly (1979) and restriction 
analysis was done for the plasmids of selected clones by using 
BamHI and PstI restriction endonucleases. 
 
 
Protein analysis and expression studies 
 
For protein analysis, about 5 ml of Luria broth with kanamycin (50 
mg/ml) and ampicillin (50 mg/ml) was inoculated with a colony of E. 
coli containing the recombinant construct and incubated at 37°C 
overnight under shaking conditions. Overnight grown culture was 
diluted in fresh Luria broth in 1:100 ratio without selection pressure 
and incubated at 37°C until the culture reached the log phase of 
growth (A550-0.5 to 1.0) under shaking conditions which will take 
approximately 3 h. The expression of target protein was induced 
based on the optimal values of IPTG (1 mM) concentration and it 
was again incubated for 5 h at 37°C in a shaker. After induction, the 
protein was extracted and analyzed by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE). For extraction of 
proteins, the cell culture was centrifuged at 13,000 rpm for 1 min at 
room temperature. The pellet was resuspended in 100 µl of T10E1 
and 100 µl of 1X SDS gel loading buffer added to it. 
The mixture was heated at 90°C on a thermo mixer and cen-
trifuged for 10 min at 4°C. The supernatant was collected in micro 
centrifuge tubes and protein was quantified by using NanoDrop. 
The protein preparations were analysed by SDS-PAGE as des-





For all investigated parameters, the analysis of variance (ANOVA) 
was performed using the MSTATC software. The measurements of 
treatments were compared using Duncan’s multiple range tests at 
the 0.01 significance level. 
 
 
RESULTS AND DISCUSSION 
 
Bioassay for insecticidal activity 
 
At 24 h, the mean percent mortality ranged between 0 to 
43.33% mortality. The highest mortality was recorded in 
DBT153 (43.33%) followed by DBT2564 (33.33%), while 
in reference strain HD1, the mortality was 46.66% (Table 
3 and Plate 1). The cumulative mean percent mortality after 
48 h exposure  ranged between 0 to 53.33%. The highest 




mortality was recorded in native isolate DBT153 (53.33%), 
followed by DBT2564 (43.33%) and DBT112 (36.66%) 
compared to reference strain B. thuringiensis subsp 
kurstaki (HD1) which showed mortality of 73.33%. At 72 h 
exposure, the cumulative mortality of third instar larvae of 
P. xylostella ranged from 0 to 100%. The reference strain 
HD1 exhibited 100% mortality, whereas DBT153 exhi-
bited 83.33% mortality. The mortality range of isolates 
was less as compared to previous reports. 
Higher toxicity of native isolates than reference strain 
(HD1) against P. xylostella was reported earlier by Shilpa 
(2005) and Marutesh (2007). 
 
 
cry profiling of native isolates 
 
The melting temperatures were standardized for each 
primer set. The specific amplicons obtained for some of 
the genes is shown in Plate 2. Most of the isolates 
showed amplification of at least one cry gene. PCR can 
be used for prediction of toxicity of isolates (Salehi et al., 
2008). Among the coleopteran specific cry genes, the 
most predominant was cry1I gene which was present in 
18 native isolates at a frequency of 7.05%. cry7,8 and 
cry3 were present in almost equal frequency of 6.66 and 
6.27%, respectively (Figure 1). Similar results were repor-
ted by Nazarian et al. (2009) which was the first explo-
ration in which B. thuringiensis isolates were screened 
almost for all coleopteran-active cry genes (19 cry genes) 
and cry1I was found to be in 48.5% frequency. cry1I and 
cry7,8 were found to be predominant in a previous study 
(Mahadeva et al., 2011). About 13 isolates amplified for 
cry14. cry18 was present in six isolates. cry26 and cry36 
were present in an equal frequency of 5.49%. About 
4.13% of the isolates contained cry34 and cry35. cry28 
was present in four isolates. Only one isolate amplified 
for cry55 and cry23. None of the isolates amplified for 
cry37. Among the reference strains HD1 amplified for 
cry1I, cry18, cry26, cry28, cry23, cry1, cry1Aa1, cry1Ab2, 
cry1Ac1, cry1Ia1, cry2Aa1 and cry2Ab1; 4AA1 amplified 
for cry3; 4AT1 amplified for cry7,8; cry8 and cry9; 4E2 
amplified for cry14. 
Many of the isolates harboured more than one cry 
genes. DBT178 harboured cry28, cry34 and cry35 where-
as cry34, cry35 and cry36 were present in DBT202. 
DBT211 contained cry1I, cry34 and cry35. DBT340 had 
cry3, cry7,8; cry26 and cry36. cry3, cry26 and cry36 were 
present in DBT344. Only one isolate amplified for cry55 
namely, DBT333 (Table 4). It was also found that the 
toxicity correlated with the number of cry genes in an 
individual isolate namely, DBT112 harboured 5 cry genes 
(cry2, cry1Aa1, cry1Ac1, cry1Ae1, cry2Ab1) and showed 
76.66% mortality. Similarly, DBT111 harboured three cry 
genes (cry2Ab1, cry1I, cry26) and showed 60% mortality 
after 72 h of treatment. Among the genes screened which 
are specific for lepidopteran pests, cry1 gene was found 
to be most abundant (35.39%) followed by cry2 (33.62%) 
(Figure 2). High frequencies of cry1 and cry2 genes




Table 3. Efficacy of native isolates of Bacillus thuringiensis against DBM [Plutella xylostella (L.)]. 
 
S/N Isolate 
Mean% mortality at different intervals after treatment  
S/N Isolate 
Mean% mortality at different intervals after treatment 
Diamondback moth  Diamond back moth 
24 HAT 48 HAT 72 HAT  24 HAT 48 HAT 72 HAT 
Coorg Isolate 

















































































































































































































































































































































































































































Table 3. Contd 
 
































































































































































































 0 (0.00)u 














































































































       

















































 0 (0.00)u 
























































































 0 (0.00)u 























 0 (0.00)u 




Table 3. Contd 
 











































































 0 (0.00)u 










 0 (0.00)u 






















































































 0 (0.00)u 










 0 (0.00)u 























 23.33 (28.76) 
nopq
 






























































 0 (0.00)u 


















































































































 0 (0.00)u 























 23.33 (28.76) 
nopq
 
























































Table 3. Contd 
 










 0 (0.00)u 






































































































































       

















 0 (0.00)u   24 h 48 h 72 h  






  SE M± 3.99 3.64 2.24 SEM± 






  CD (1%) 14.62 13.33 8.22 CD (1%) 






  CV (%) 47.93 33.69 15.31 CV (%) 
 




were found in the B. thuringiensis collection which 
was similar to that described in other reports 
(Bendov et al., 1997; Bravo et al., 1998; Kim, 
2001; Wang et al., 2003), whereas, cry9 gene dis-
played the lowest frequency. The study on the 
diversity of cry gene combinations in Thailand 
revealed that cry1 and cry2 genes often appeared 
together, which is similar to the observations from 
Israel (Ben-Dov et al., 1997) and China (Kim, 
2001; Wang et al., 2003). cry1Ad1 and cry1Ca1 
was present only in two isolates. None of the iso-
lates amplified for cry1Da1. 23.89% of the isolates 
amplified for cry2Ab1. 
About 13 isolates amplified for cry1Ia1 and 12 
isolates for cry1Aa1. cry2Aa1 and cry1Ac1 was 
present in 19 isolates. Six isolates amplified for 
cry2Ac1 and three isolates for cry9Aa1; cry1Ae1 
was found in 17 isolates. cry9Ca1 was present in  
4.42% of the isolates. About five isolates contained  
cry1Ab2 (Table 5 and Figure 3). It has been repor-
ted that most of the commercial Bt formulations 
used for the control of Lepidopteran pests contain 
toxins of Cry1A family, especially Cry1Aa, Cry1Ab 
and Cry1Ac proteins (Hofte and Whiteley, 1989). 
The diversity of cry gene profiles suggest that 
there could be different strains of Bt which could 
be toxic to insects belonging to order Lepidoptera 
and Coleoptera. There may be more than one cry 
gene in a given isolate. Martinez and Caballero, 




Analysis by amplicon fragment length 
polymorphism (ARFLP) 
 
The cry1I amplicons of DBT189 and DBT212 was 
restricted with restriction endonucleases EcoRI, 
NheI and XbaI. The pattern of restriction was 
similar to that of the reference strain HD1. But 
when the PCR amplicon of DBT189 was restricted 
with HindIII, there were differences in restriction 
fragments in relation to the reference strain HD1. 
There was one HindIII site in the isolate DBT189 
giving rise to 1584 and 585 bp bands as com-
pared to the reference strain HD1 which gave res-
tricted fragments of 1300, 585 and 284 bp indica-
ting the presence of two HindIII sites in HD1 
(Plate 3). PCR-RFLP is the first method speci-
fically designed to detect novel cry genes (Kuo 
and Chak, 1996). It was also used by Wang et al. 
(2003) to detect new cry genes. 
 
 
Cloning and nucleotide sequencing 
 
cry1I gene fragments of about 2.1 kb amplified by 
PCR from the genomic DNA of Bt isolate DBT189 
was cloned into a cloning vector pTZ57R/T and this










construct was transferred into E. coli DH5α and transfor-
mants were confirmed by restriction analysis using BamHI 
and PstI endonucleases separately giving rise to linear 
fragment of 5.05 kb including both vector and insert. This 
construct was named as pAPK101. A computer based 
homology search program of NCBI revealed that the 
gene is a novel cry1I-type gene. The construct pAPK101 
containing full length cry1I was sequenced through 
primer walking employing M13 primers. The available 
sequence information from cloned fragments was analy-
sed using BLAST algorithm available at 
http://www.ncbi.nlm.nih.gov. Multiple alignment of amino











Plate 2. Screening of native Bt isolates harbouring coleopteran and lepidopteran specific cry genes. 






Figure 1. Distribution of coleopteran active cry-type genes in 255 B. thuringiensis isolates identified by 




Table 4. Native Bacillus thuringiensis isolates showing the presence of cry genes toxic to Coleopterans in Coorg and BR Hills isolates. 
 
cry gene  Isolate Number 
cry1I 
DBT105, DBT107, DBT139, DBT167, DBT182, DBT183, DBT189, DBT210, DBT211, 
DBT212, DBT111, DBT 136, DBT200, DBT265, DBT268, DBT321 DBT352, DBT369 
17 
   
cry3 
DBT141, DBT142, DBT199, DBT200, DBT258, DBT311, DBT312, DBT340, DBT343, 
DBT344, DBT347, DBT360, DBT367, DBT368, DBT369, DBT370 
16 
   
cry7,8 
DBT 104,DBT173, DBT 181, DBT 191, DBT310, DBT321, DBT340, DBT345, 
DBT356, DBT358, DBT368, DBT243, DBT246, DBT265, DBT268, DBT291, DBT235 
17 
   
cry14 
 DBT105, DBT136, DBT140, DBT143, DBT161, DBT174, DBT183, DBT210, 
DBT245, DBT249, DBT250, DBT317, DBT346 
13 
   
cry18 DBT190, DBT258, DBT264, DBT273, DBT317, DBT346 6 
   
cry23 DBT 171 1 
   
cry26 
DBT111, DBT118, DBT131, DBT142, DBT171, DBT245,DBT247,DBT333, DBT340, 
DBT343, DBT344, DBT345, DBT347, DBT354 
14 
   
cry28 DBT158, DBT178, DBT248, DBT258 4 
   
cry34 DBT128, DBT178, DBT201, DBT202, DBT211, DBT235 6 
   
cry35 DBT128, DBT178, DBT201, DBT202, DBT211, DBT235 6 
   
cry36 
DBT197, DBT202, DBT242, DBT254, DBT259, DBT264, DBT312, DBT340, DBT343, 
DBT344, DBT347, DBT352, DBT360, DBT367 
14 
   
cry55 DBT333 1 
   




acid sequence of pAPK101 showed 99% homology to 
that of published cry1I sequence. It encoded a protein 
consisting of 720 amino acids. The sequence was sub-
jected to further analysis in BT1 software of GENETOOL 
for finding the restriction sites and NCBI open reading 
frame search database for finding the ORF. The sequence 
analysis revealed the same results as that observed in 
the ARFLP pattern (Table 6). 











Table 5. Native Bacillus thuringiensis isolates showing the presence of cry genes toxic to Lepidopterans in Coorg isolates. 
 
cry gene Isolate Number 
cry1 
DBT120, DBT125, DBT128, DBT123, DBT 126, DBT140, DBT146, DBT172, DBT159, DBT155, DBT160, DBT195, 
DBT162, DBT165, DBT170, DBT157, DBT178, DBT185, DBT174, DBT150, DBT105, DBT210, DBT211, DBT212, 
DBT135, DBT139, DBT107, DBT167, DBT149, DBT133, DBT156, DBT138, DBT143, DBT115, DBT144, DBT129, 
DBT137, DBT154, DBT203, DBT183 
40 
   
cry2 
DBT148, DBT152, DBT192, DBT206, DBT153, DBT173, DBT181, DBT182, DBT184, DBT189, DBT190, DBT193, 
DBT196, DBT197, DBT201, DBT202, DBT209, DBT 164, DBT178, DBT198, DBT123, DBT158, DBT147, DBT151, 
DBT197, DBT194, DBT204, DBT186, DBT199, DBT177, DBT188, DBT180, DBT169, DBT109, DBT100, DBT106, 
DBT116, DBT112 
38 
   
cry8 DBT156, DBT166 2 
cry9 DBT179, DBT186, DBT188, DBT192 4 
cry20 DBT134, DBT145, DBT178, DBT179, DBT180, DBT207 6 
   
cry1Aa1 DBT192, DBT173, DBT182, DBT184, DBT190, DBT197, DBT179, DBT204, DBT112, DBT104, DBT117, DBT121 12 
   
cry1Ab2 DBT116, DBT172, DBT195, DBT185, DBT107 5 
   
cry1Ac1 
DBT182, DBT190, DBT178, DBT123, DBT147, DBT186, DBT177, DBT169, DBT113, DBT109, DBT100, DBT106, 
DBT116, DBT124, DBT110, DBT112, DBT102, DBT104, DBT125 
19 
   
cry1Ad1 DBT126 1 
   
cry1Ae1 
DBT112, DBT102, DBT104, DBT120, DBT125, DBT128, DBT126, DBT175, DBT146, DBT172, DBT159, DBT155, 
DBT160, DBT161, DBT162, DBT170, DBT185 
17 
   
cry1Ca1 DBT146 1 
cry1Da1 - - 
cry1Ea1 DBT122, DBT185 2 
cry1Fa1 DBT142, DBT171, DBT195 3 
cry1Ia1 
DBT194, DBT204, DBT186, DBT199, DBT177, DBT188, DBT191, DBT113, DBT106, DBT117, DBT183, DBT105, 
DBT211 
13 
   
cry2Aa1 
DBT207, DBT166, DBT148, DBT176, DBT192, DBT153, DBT182, DBT184, DBT193, DBT197, DBT205, DBT208, 
DBT209, DBT164, DBT178, DBT158, DBT147, DBT113, DBT109 
19 
   
cry2Ab1 
DBT148, DBT152, DBT192, DBT206, DBT153, DBT181, DBT182, DBT184, DBT189, DBT193, DBT196, DBT203, 
DBT178, DBT123, DBT158, DBT147, DBT197, DBT186, DBT177, DBT191, DBT100, DBT116, DBT124, DBT112, 
DBT102, DBT104, DBT118, DBT111 
27 




Table 5. Contd. 
 
cry2Ac1 DBT150, DBT155, DBT193, DBT197, DBT210, DBT211 6 
cry9Aa1 DBT121, DBT126, DBT133 3 






Plate 3. ARFLP pattern. M: λ DNA digested with EcoRI and HindIII; Lane 1: PCR product of HD1 
undigested; Lane 2: PCR product of HD1 digested with HindIII; Lane 3: PCR product of DBT189 
undigested, Lane 4: PCR product of DBT189 digested with HindIII; Lane 5: PCR product of DBT212 




The conserved domains of the cloned cry1I sequence 
were analysed using NCBI CDD search database. The 
toxic domain of cry1I ranged between 60 to 640 amino 
acids and contained N, M and C super family domains of 
endotoxins which include most of the N-terminal region 
which indicates its toxic potential. The alignment of Cry1I 
(pAPK101) and reference strain B. thuringiensis sub sp. 
kurstaki (Accession No. AJ315121.1) revealed changes 
in six amino acids at the position 15, 217, 426, 657, 711 
and 712 amino acid residues. Different Cry proteins vary 
in toxicity against one insect species, while different 
insect species vary in susceptibility to a particular Cry 
protein. This variability may be due to significant differen-
ces in the amino acid sequence between proteins 
(Barboza et al., 1998) but occasionally the toxicity of a 
particular Cry protein may vary considerably owing to 
minor differences in sequences. Minor differences from a 
holotype sequence are frequently found in nature and are 
considered to be ‘natural variants’; however, no relation-
ship has been established between this variability and 
adaptability. Most of these differences normally have no 
effect on toxicity, except when they occur in particular 
regions of the molecule. Because the toxic effect of Cry1 
proteins is restricted to the N-terminal half of the mole-
cule (δ endotoxin), any difference in activity may be 
attributed to the amino acid differences in this moiety. 
Multiple alignment of amino acid of pAPK101 with 
reference AJ315121.1 revealed six amino acid substitu-
tions: N for X (position 15 bp), G for X (position 217 bp), 
K for E (position 426 bp), Q for R (position 657), N for K 
(position 711) and E for Q (position 712). This resulted in 
substitution of amino acids: K (lysine) to E (glutamic 
acid), Q (glutamine) to R (arginine), N (asparagine) to K 
(phenylalanine) and E (glutamic acid) to Q (glutamine) 
(Figure 3). The N-terminal region (from M1-Q10) consists 
of positively charged amino acids which may function as 
a signal peptide. According to the results described by 
Kostichka et al. (1996), the analysis of the deduced cry1I 
protein sequence of the T01328 isolate also revealed the 






The gene of interest was cloned and expressed in pQE30 
giving rise to a recombinant vector of 5630 bp. The 
confirmation of the cloned gene was on the basis of 
release of insert of 2169 bp along with vector and insert 
5630 bp (Plate 4). SDS-PAGE analysis revealed that a 
81 kDa protein was produced in E. coli induced with IPTG 
(Plate 5). Similar protein with a molecular weight of appro-







Figure 3. Alignment of amino acid of Cry1I (pAPK101) with AJ315121.1. 










Plate 4. Restriction confirmation of cry1I clones in E.coli M15 and SG13009. M: λ 
DNA HindIII digest; Lanes 1, 3, 5, 7, 9: uncut plasmid; Lanes 2, 4, 6, 8, 10, 12: 






Plate 5. Detection of the recombinant protein in a 10% SDS gel. Lanes 1, 3 and 5: 
Proteins from induced clones; Lanes 2, 4 and 6: Proteins from uninduced clones; Lane 
7: Protein from induced host E. coli M15 (pREP4); Lane 8: Protein from uninduced host 
E. coli M15 (pREP4); Lanes 9 and10: Proteins from the E. coli cell extract with the 
empty vector; M: Prestained Protein Ladder marker SM0671. 




Table 6. Amplicon restriction fragment length polymorphism of full length cry1I. 
 
Enzyme 
Restriction fragment size (bp) 
HD1 DBT189 DBT212 
HindIII 1300, 585 and 284 1584, 585 1300, 585 and 284 
EcoRI 1450, 719 1450, 719 1450, 719 
NheI 1700, 469 1700, 469 1700, 469 




ximately 81 kDa was observed in a study conducted by 
Bergamsco et al. (2011). Cry1I toxins are of special 
interest since they present toxicity against insects of the 
Lepidoptera and Coleoptera orders. Other proteins, as 
Cry1B, Cry1C and Cry2A have also been found to exhibit 
action against more than one order (Zhong et al., 2000; 
Widner and Whiteley, 1990). Cry-type proteins (for exam-
ple, Cry1A, Cry1A, Cry2A, Cry3A and Cry9C-type) have 
been widely applied in transgenic plants, but the problem 
of narrow insecticidal spectrum and insect resistance 
have recently been observed due to lengthy use of high 
concentrations of a single Bt toxin (Romeis et al., 2006). 
Most of the toxins cloned consist of lepidopteran active 
proteins till now, thus, search for more Bt strains 
harbouring coleopteran specific genes is important. 
The cry1I protein may prove to be an alternative to 
combat the insect resistance problem and so it will be 
worthwhile to fully elucidate its insecticidal potential. Fur-
ther studies are in progress to ascertain the nature of the 
protein and its novelty and toxicity tests are being carried 
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